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High-throughput chromatin accessibility
profiling at single-cell resolution
Anja Mezger1,2, Sandy Klemm1, Ishminder Mann3, Kara Brower4, Alain Mir3, Magnolia Bostick3,
Andrew Farmer3, Polly Fordyce1,4,5,6, Sten Linnarsson 2 & William Greenleaf 1,6,7
Here we develop a high-throughput single-cell ATAC-seq (assay for transposition of
accessible chromatin) method to measure physical access to DNA in whole cells. Our
approach integrates fluorescence imaging and addressable reagent deposition across a
massively parallel (5184) nano-well array, yielding a nearly 20-fold improvement in
throughput (up to ~1800 cells/chip, 4–5 h on-chip processing time) and library prepara-
tion cost (~81¢ per cell) compared to prior microfluidic implementations. We apply this
method to measure regulatory variation in peripheral blood mononuclear cells (PBMCs) and
show robust, de novo clustering of single cells by hematopoietic cell type.
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A central challenge of systems biology is to determine theepigenome of phenotypically distinct cellular states withincomplex primary tissue. Toward this goal, single-cell
chromatin accessibility measurements provide an important
epigenetic view of the regulatory landscape within individual cells
by capturing the physical accessibility of putative functional ele-
ments across the genome1–6. Methods for measuring chromatin
accessibility at single-cell resolution, however, are low through-
put, depth limited, or require complex molecular processing to
generate cellular indexing reagents2–5,7. For ultra-high through-
put accessibility profiling applications, combinatorial indexing
approaches2,7 offer significant promise, yet these methods capture
fewer accessible fragments per cell than single-cell isolation
technologies1,3 and are not amenable to integration with single-
cell microscopy or other multi-omic assays that require whole,
live cells. In this report, we describe a high-throughput imple-
mentation of single-cell ATAC-seq8 (scATAC-seq) that directly
integrates fluorescence imaging and provides an extensible
foundation for multi-omic epigenetic profiling in single cells.
Results
Implementation of scATAC-seq on nanoliter-scale wells. We
have implemented scATAC-seq in small volumes (µATAC-seq)
using a recently developed nanoliter-scale liquid deposition sys-
tem (ICELL8 Single Cell System, Takara Bio USA). This approach
reduces reagent costs and achieves equal or higher per-cell frag-
ment counts than prior state-of-the-art implementations2,3,7. The
workflow—illustrated in Figure 1a—is comprising of the follow-
ing steps: (1) isolated single cells are stained with Hoechst and
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Fig. 1 µATAC-seq: a nano-well scATAC-seq implementation on the ICELL8 platform. a µATAC-seq workflow. b Distribution of cell counts per well
measured by fluorescence microscopy (Hoechst). c µATAC-seq library complexity for null, mouse, and human targeted wells using two separate
polymerases (e2Tak and Q5) for well barcoding and amplification (n= 5000 wells). For each sample, the box denotes the interquartile range centered at
the median (red line), while the whiskers span the 5th and 95th percentile range. d Correlation between nano-well chips processed with either a e2Tak
(replicate 1) or Q5 polymerase (replicate 2) across all accessible loci. e Inter-well mixing of mouse and human µATAC-seq fragments. f Representative
population22 and single-cell ATAC-seq genome tracks for the Gapdh locus. g Signal-to-background (percent reads in peaks) as a function of read depth
(n= 792). Only cells lying in the upper right quadrant (marked by dashed lines) are retained for downstream analysis
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propidium iodide and stochastically loaded under Poisson sta-
tistics (~1 cell per well on average) across 5184 wells under active
humidity and temperature control; all wells are then imaged via
multi-color microscopy to identify those containing a single-live
cell; (2) transposition reagents are added to a selected set of wells
(e.g., those containing a single live cell) and incubated at 37 °C for
30 min; (3) the transposition reaction is quenched by incubation
with EDTA; (4) MgCl2 is added in equimolar concentration to
quench the chelating capacity of EDTA in preparation for sub-
sequent PCR amplification; (5) PCR reagents are added and
µATAC-seq fragment libraries are amplified using barcoded
primers provided in the prior two steps (see Supplementary
Table 1 for reagent loading chart). Following on-chip library
construction, indexed µATAC-seq libraries are extracted from all
nano-wells by centrifugation, purified, and then further amplified
as necessary for sequencing (Methods section).
Benchmarking analysis of µATAC. As an initial test of µATAC-
seq, we loaded samples into 5000 wells across two nano-well
ICELL8 chips. On each chip, 200 wells were loaded with PBS
(designated null wells); 1150 wells were loaded with mouse
embryonic stem cells (mESCs, ~1 cell per well); and 1150 wells
loaded with human lymphoblastoid GM12878 cells (~1 cell per
well). This yielded a total of 4600 wells targeted with either
human or mouse cells across both chips. Imaging of Hoechst and
propidium iodide fluorescence revealed the anticipated fraction of
wells containing live single cells (35%, 1616 single cells), con-
sistent with near optimal loading that maximizes the number of
single-cell containing wells (Fig. 1b). Barcoded sequencing of each
of the 5000 targeted wells revealed 14.3 × 103 (8.1 × 103) median
fragments per single human (mouse) cell containing wells
(n= 1616)—reflecting a two orders of magnitude enrichment over
null wells (Fig. 1c and Supplementary Figure 1a,b). These library
complexities compare favorably with microfluidic cell capture
(5.8 × 103 fragments per GM12878 cell3) as well as combinatorial
indexing (2.5 × 103 fragments per GM12878 cell7) approaches.
The µATAC-seq libraries capture both sub-nucleosome as well as
nucleosome length fragments, yet, the median fragment length is
shorter than that observed using the Fluidigm C1 platform.
Consistent with prior bulk and single-cell ATAC-seq libraries, we
observe a more than tenfold enrichment for fragments proximal to
transcription start sites (TSS) relative to distal regions, reflecting a
high fraction of fragments captured within open rather than
closed chromatin (Supplementary Figure 2a). Furthermore, we
find a high degree of concordance (97.9%) between nano-well
chips even when µATAC-seq fragments are amplified with dif-
ferent polymerases (Fig. 1d). We further tested the deposition
fidelity of the ICELL8 platform, observing both human and mouse
cells in fewer than 0.2% of wells (Fig. 1e).
Aggregate single-cell profiles recapitulate population measure-
ments broadly across the accessible genome (Supplementary
Figure 2b) as well as specifically at individual genomic loci
(Fig. 1f). At single-cell resolution, accessibility profiles are
enriched for open chromatin (Fig. 1f, g) in both mESCs (29%
reads in peaks, Fig. 1g) and GM12878 cells (22% reads in peaks,
Supplementary Figure 2c). Collectively, these data establish the
proposed nano-well implementation as a high-throughput frame-
work for scATAC-seq library construction.
Epigenetic signature distinguishes PBMC types. We next asked
whether µATAC-seq epigenetic profiles are sufficient to distin-
guish cell types within complex primary tissue. For this purpose,
we performed µATAC-seq on human peripheral blood mono-
nuclear cells (PBMCs) as well as B, T, CD4+ T, CD8+ T, and
monocyte cells isolated directly from whole blood (Fig. 2a),
yielding 2333 single cells passing all quality control criteria
(Methods section). Using ChromVar, a bioinformatic approach
described previously9, we calculated the relative accessibility of
transcription factor (TF) binding motifs in individual cells and
found that isolated B, T, and monocyte cells robustly cluster by
cell type (Supplementary Figure 3a). By aggregating fragments
within single cells that are proximal to a TF motif, this epigenetic
signature captures the variation in putative TF binding site
accessibility across a population of cells9. A relatively small
fraction of cells are incorrectly assigned to clusters; however, the
frequency of these events as well as the random distribution of
these cells within apposing clusters both suggest that isolation
impurity upstream of the µATAC-seq assay is the primary source
of these errors (Supplementary Table 2). PBMC subpopulations
co-cluster precisely with the isolated cell types (Fig. 2b, c),
showing highly concordant cell type-specific accessibility patterns
within appropriate tSNE10 (t-Distributed Stochastic Neighbor
Embedding) clusters (Fig. 2c) as well as k-means clustering across
highly variable TF binding motif accessibility patterns (Fig. 2b).
Consistent with published gene expression data, we find that the
PU.1 binding motif is differentially accessible in monocytes and B
cells relative to T cells (Fig. 2c, upper right panel)11,12, the C/
EBPα motif is exclusively accessible in monocytes (Fig. 2c, lower
left panel)13,14, and RUNX1 motif accessibility is appropriately
enriched in T cells—reflecting the broad regulatory role of the
RUNX protein family in T lymphocytes (Fig. 2c, lower right
panel)15. These results are highly robust to biological (three
human blood donors) and technical variation (Supplementary
Figure 3b). To further establish the robustness of clustering by cell
type, we independently purified CD4+ and CD8+ T cells and
found that these subtypes co-cluster with independently isolated
T cells (Fig. 2c, upper left panel). Collectively, these data suggest
that µATAC-seq signatures are sufficient for de novo clustering of
PBMCs by hematopoietic cell type.
Discussion
In this report, we have described µATAC-seq—a high-through-
put, single-cell chromatin accessibility assay that dramatically
reduces per-cell costs, requires only commercially available
reagents, provides state-of-the-art data quality, and increases
throughput nearly 20-fold over existing single-cell capture tech-
nologies. Single-cell chromatin measurements present a unique
experimental challenge since only two DNA templates are present
in a diploid cell. Technical sampling noise as well as biological
heterogeneity further confound this problem, resulting in a ~10%
observation efficiency of accessible regions in single cells3. Con-
sequently, a few hundred cells are typically required to reliably
determine the accessibility landscape of each subpopulation
within a mixture of cells. Our approach in this work has been to
develop an experimental framework for processing more than a
thousand of cells in parallel to determine the accessibility of
multiple cell types within a complex tissue. In general, nano-well
single-cell sequencing approaches such as µATAC-seq are highly
extensible, well-suited for multi-omic analysis, and define an
important direction for single-cell epigenetic methods
development.
Methods
Cell culture. All cell lines were grown at 37 °C with 5% CO2. GM12878 cells were
obtained from the laboratory of Michael Synder (Stanford Univeristy) and were
cultured in RPMI 1640 media supplemented with L-glutamine (Thermo Fisher
Scientific, MA, USA, Cat. #11875–085) and 10% FBS (Thermo Fisher Scientific,
Cat. #10082147); mESC cells (129S1X Castaneous, gift from Howard Chang) were
cultured in 15% FBS (HyClone GE Healthcare Life Sciences, SH30070.03E) sup-
plemented with non-essential amino acids, L-glutamine and Leukemia Inhibitory
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Factor (LIF, Invitrogen, Cat. #A35935). Adherent mESCs were washed twice in 1X
PBS and detached using trypsin (Sigma, MO, USA) for 5 min. Cells were diluted in
their respective media, collected by centrifugation at 400 g for 5 min, and then
resuspended in media.
Immune cell isolation from whole blood. Monocytes, T cells, CD4+ T cell, CD8+
T cells, and B cells were isolated from whole blood (AllCells, CA, USA) using
EasySep Direct Human cell isolation kits (STEMCELL Technologies, MA, USA)
according to the manufacturer’s protocol. Isolated PBMCs (AllCells, CA, USA)
were thawed in RPMI and washed once in media before staining the cells as
described below. All human cells were obtained from AllCells with explicit consent
to publish data for broad genomic release.
ICELL8 workflow. Cells were stained with Hoechst and propidium iodide using the
ReadyProbes Cell Viability Imaging Kit (Thermo Fisher Scientific) for 20 min in
media at 37 °C, then washed twice in cold 0.5X PBS. Cells were counted and
dispensed into nano-wells using the SMARTerTM ICELL8® Single-Cell System
(Takara Bio USA, CA, USA, Cat. #640000) at 25 cells/µl in 0.5X PBS, 1X Second
Diluent (Takara Bio USA, Cat. # 640196) and 0.4 U/µl RNase Inhibitor (New
England Biolabs [NEB], MA, USA) into a SMARTer ICELL8 250v chip (Takara Bio
USA, Cat. #640183). Control wells containing 1X PBS (25 µl) and fiducial mix
(25 µl) (Takara Bio USA, Cat. #640196) were included in the source loading plate
(see source plate loading chart in Supplementary Table 1). The on-chip deposition
volume was 40 nl for all reagent delivery steps. The chips were maintained at 16 °C
or lower between all reagent loading steps. Following cell deposition, chips were
sealed with SMARTer ICELL8 imaging film (Takara Bio USA, Cat. #640014) and
centrifuged at 400 g for 5 min at 4 °C and imaged with a 4× objective using Hoechst
and propidium iodide fluorescence. Images were analyzed using automated
microscopy image analysis software (CellSelect, Takara Bio USA). Immediately
following imaging, the Tn5 transposition mix (2X TD buffer [20% dimethylfor-
mamide, 20 mM Tris-HCl, pH 7.6, 10 mM MgCl2], 100 µl Tn5 transposase
[Nextera DNA Library Prep Kit, Illumina, CA, USA] per ml Tn5 transposition mix,
0.2% Tween 20, 0.2% NP40, and 0.02% Digitonin [Promega, WI, USA]) was dis-
pensed. Chips were then sealed with imaging film, centrifuged at ~3000 g for 5 min
at 4 °C and incubated for 30 min at 37 °C. To index the whole chip, 72 i5 and 72 i7
previously published, custom indices (Supplementary Table 3)3 were dispensed at
6.25 µM concentration with EDTA and MgCl2, respectively. To release the bound
Tn5 transposase, 60 mM EDTA was dispensed together with the i5 indexes. After
sealing the chip, it was centrifuged at 3000 g for 3 min and incubated for 30 min at
50 °C. Prior to performing PCR on-chip, the chelating capacity of EDTA was
suppressed by dispensing 60 mM MgCl2 together with the i7 indices. Chips were
then sealed with imaging film, centrifuged, and incubated at room temperature for
5 min. Finally, a PCR mix (5x Q5 [NEB] or e2TAK [Takara Bio USA] reaction
buffer, 1 mM dNTPs [Thermo Fisher Scientific], and 100 U/ml Q5 [NEB] or 50 U/
ml e2TAK polymerase [Takara Bio USA], respectively) was dispensed and 14 cycles
of PCR were performed on-chip after sealing with TE Sealing film (Takara Bio
USA, Cat. #640109) and centrifuging at ~3000 g (3 min) as follows: 5 min at 72 °C
and 30 s at 98 °C followed by 14 cycles of 10 sec at 98 °C and 90 s (Q5 polymerase)
or 150 s (e2TAK polymerase) at 72 °C, with a final extension of 2 min at 72 °C. PCR
products were extracted by centrifugation at ~3000 g for 10 min using the supplied
SMARTer ICELL8 Collection Kit (Takara Bio USA). All dispense and sealing steps
were followed by centrifugation at ~3000 g for 3 min. All on-chip thermal cycling
was performed using a SMARTer ICELL8 Thermal Cycler (Takara Bio USA).
Off-chip purification and additional amplification. The collected PCR product
was purified using MinElute PCR purification columns (Qiagen, Germany) fol-
lowing the manufacturer’s instructions. Due to the large sample volume, the PCR
product was split across four MinElute columns, eluted in 10 µl volumes, and
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subsequently pooled. To remove free PCR primers, which would induce index-
swapping during additional rounds of off-chip amplification, we performed two
rounds of bead clean-up using Ampure XP beads (Beckman Coulter, CA, USA) in
a 1:1.2 ratio. The beads were incubated for 8 min with the PCR product, washed
twice in 70% ethanol, and eluted in 20 µl ultrapure water (Thermo Fisher Scien-
tific). Further amplification was required only for the mouse and human mixing
experiment. PBMCs libraries generated on-chip were directly sequenced following
column and bead purifications.
The number of required off-chip amplification cycles was determined by
running a 20 µl qPCR reaction (2 µl PCR product, 0.5 µM oligo C [Illumina P5],
0.5 µM oligo D [Ilumina P7], 0.6X SYBR Green I [Thermo Fisher Scientific], and
1X NEBNext High-Fidelity 2X PCR Master Mix [NEB]): 30 s at 98 °C, followed by
20 cycles of 10 s at 98 °C and 30 s at 63 °C and 1min at 72 °C. The remaining 18 µl
PCR product was amplified the number of PCR cycles corresponding to 1/3 of the
maximum fluorescence intensity. The amplified PCR product was then purified
and concentrated using a Qiagen MinElute column.
DNA sequencing. All libraries were sequenced on a NextSeq 500 (Illumina) using
the high output v2 kit (Illumina) in 76 × 8 × 8 × 76 cycle mode, although 38 bp ×
8 × 8 × 38 bp sequencing is sufficient. On average, ~50 K reads were sequenced per
cell. Due to the nature of the sequencing libraries 30–40% phiX control v3 (Illu-
mina) was spiked in and 1.5 pM were loaded onto the flow cell.
Per cell cost estimate. The per cell library preparation cost is conservatively
estimated (assuming only 1200 single cells captured per chip) at 81¢/cell: (1)
Takara Bio ICELL8 chip (52¢/cell), (2) Illumina Tn5 (24¢/cell), (3) e2Tak poly-
merase (4¢/cell), (4) other reagents contribute <1% additionally. The additional per
cell sequencing cost at the depth used for this report (assuming a 75 cycles NextSeq
500/550 High Output v2 Kit) is approximately 17¢/cell. .
Data analysis. Illumina sequencing reads in BCL format were demultiplexed by
single-cell barcode to fastq files using bcl2fastq (Illumina) according to the man-
ufacturer’s manual. Reads were trimmed using Cutadapt16 (parameters: -a
Trans2_rc=CTGTCTCTTATACACATCTCCGAGCCCACGAGACA, Trans1_rc
= CTGTCTCTTATACACATCTGACG CTGCCGACGA) and aligned to either
the human (hg19) or mouse (mm9) genomes using Bowtie217. Mitochondrial reads
were removed prior to downstream analysis. PCR duplicates were identified and
removed if either the start or end position was shared with another sequencing
read. Library complexity estimates were obtained using the Picard Tools Mark-
Duplicates utility (https://broad-institute.github.io/picard/), except for emtpy well
where too few reads were present for a robust estimate; in the latter case, the library
complexity was estimated as the number of unique reads observed. Accessible
chromatin regions (peaks) were determined using MACS218 (parameters: --format
BAMPE --nomodel --call-summits --nolambda --keep-dup all) for mouse
embryonic stem cells (mESCs) and human lymphoblastoid (GM12878) cells. A
previously published accessible peak set for hematopoiesis was used for PBMC, T-
and B-cell analysis1. Single cells were selected based on imaging using the supplied
ICELL8 CellSelect software (Takara Bio USA). Primary PBMCs with fewer than
500 unique (non-mitochondrial) reads or with <20% (10–15% for mESCs and
GM12878 cells) of mappable reads lying within peaks were eliminated from sub-
sequent analysis. Bias-corrected deviations in accessibility near transcription factor
motifs were calculated using ChromVar9. Bias-corrected deviations were linearly
transformed to truncated z-scores with minimum and maximum values of −2 and
2, respectively. K-means clustering (k= 3) was performed on the 50 most variable
transcription factor motifs to assign each single cell to a specific cluster. Tran-
scription factors (rows) were then hierarchically clustered using the ward.D2
agglomeration method19,20 within the R pheatmap package21, while single cells
(columns) were ordered by assigned cluster and cell type (Fig. 2b). Visualizations of
clustering and tSNE10 analyses were constructed using R scripts.
Data availability
The sequencing data that support the findings of this study are available in Figshare
under the following DOIs: Metadata: doi: 10.6084/m9.figshare.7006154.v1; Human
monocyte cells: doi: 10.6084/m9.figshare.7005707.v1; Human lymphoblast cells
(GM12878): doi: 10.6084/m9.figshare.7005713.v1; Human peripheral blood mononuclear
cells (PBMCs): doi: 10.6084/m9.figshare.7005752.v1; Mouse embryonic stem cells
(mESCs): doi: 10.6084/m9.figshare.7005710.v1; Human CD8+ T cells: doi: 10.6084/m9.
figshare.7005701.v1; Human CD4+ T cells: doi: 10.6084/m9.figshare.7005698.v1; Human
T cells: doi: 10.6084/m9.figshare.7005683.v1; Human B cells: doi: 10.6084/m9.
figshare.7005539.v1. All other data are available from the authors upon reasonable
request.
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